PARVG (parvin gamma) is a member of the parvin family of actin-binding proteins that localizes to focal adhesions and plays a role in cell adhesion and cytoskeletal organization 1. The protein functions in promoting cell adhesion and spreading of leukocytes in conjunction with integrin-linked kinase (ILK). PARVG exhibits significant expression variability, with genetic polymorphisms (rs139144 and rs5764592) explaining approximately 20% of gene expression variation 1. In disease contexts, PARVG shows differential expression patterns across multiple cancer types. In endometrial cancer, elevated PARVG expression is associated with favorable prognosis and increased immune cell infiltration, including T cells, B cells, mast cells, and neutrophils 2. The gene has been identified as a potential tumor antigen candidate for anti-cancer vaccine development in endometrial carcinoma 3. PARVG also demonstrates differential methylation in rheumatoid arthritis B cells 4 and altered expression in diabetes 5 and chemotherapy-resistant small-cell lung cancer 6. However, mutation analyses have ruled out PARVG as a tumor suppressor gene in colorectal, breast, and oligodendroglial cancers 78. The gene's role appears to be primarily regulatory rather than oncogenic, with clinical significance as a prognostic biomarker and potential therapeutic target.